The landscape of selection in 551 Esophageal Adenocarcinomas defines genomic biomarkers for the clinic

AM Frankell; S Jammula; X Li; G Contino; S Killcoyne; S Abbas; J Perner; L Bower; G Devonshire; E Ococks; N Grehan; J Mok; M O’Donovan; S MacRae; M Eldridge; S Tavare; RC Fitzgerald; the Oesophageal Cancer Clinical and Molecular Stratification (OCCAMS) Consortium

doi:10.1101/310029

New Results

The landscape of selection in 551 Esophageal Adenocarcinomas defines genomic biomarkers for the clinic

AM Frankell, View ORCID ProfileS Jammula, X Li, View ORCID ProfileG Contino, View ORCID ProfileS Killcoyne, S Abbas, View ORCID ProfileJ Perner, View ORCID ProfileL Bower, View ORCID ProfileG Devonshire, E Ococks, N Grehan, J Mok, M O’Donovan, S MacRae, M Eldridge, S Tavare, RC Fitzgerald, the Oesophageal Cancer Clinical and Molecular Stratification (OCCAMS) Consortium

doi: https://doi.org/10.1101/310029

AM Frankell

1MRC cancer unit, Hutchison/MRC research centre, University of Cambridge, Cambridge, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

S Jammula

2CRUK Cambridge institute, University of Cambridge, Cambridge, UK.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for S Jammula

X Li

1MRC cancer unit, Hutchison/MRC research centre, University of Cambridge, Cambridge, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

G Contino

1MRC cancer unit, Hutchison/MRC research centre, University of Cambridge, Cambridge, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for G Contino

S Killcoyne

1MRC cancer unit, Hutchison/MRC research centre, University of Cambridge, Cambridge, UK

3European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Hinxton, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for S Killcoyne

S Abbas

1MRC cancer unit, Hutchison/MRC research centre, University of Cambridge, Cambridge, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

J Perner

2CRUK Cambridge institute, University of Cambridge, Cambridge, UK.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for J Perner

L Bower

2CRUK Cambridge institute, University of Cambridge, Cambridge, UK.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for L Bower

G Devonshire

2CRUK Cambridge institute, University of Cambridge, Cambridge, UK.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for G Devonshire

E Ococks

1MRC cancer unit, Hutchison/MRC research centre, University of Cambridge, Cambridge, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

N Grehan

1MRC cancer unit, Hutchison/MRC research centre, University of Cambridge, Cambridge, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

J Mok

1MRC cancer unit, Hutchison/MRC research centre, University of Cambridge, Cambridge, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

M O’Donovan

4Department of Histopathology, Cambridge University Hospital NHS Trust, Cambridge, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

S MacRae

1MRC cancer unit, Hutchison/MRC research centre, University of Cambridge, Cambridge, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

M Eldridge

2CRUK Cambridge institute, University of Cambridge, Cambridge, UK.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

S Tavare

2CRUK Cambridge institute, University of Cambridge, Cambridge, UK.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

RC Fitzgerald

1MRC cancer unit, Hutchison/MRC research centre, University of Cambridge, Cambridge, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Abstract
Full Text
Info/History
Metrics
Supplementary material
Preview PDF

Lollipop plots for Driver gene mutations
Supplementary Figures 1-8 Tables 4,6, 7
Supplementary Tables 1-3, 5

Supplementary figures 1-11 Supplementary tables 6,7,9,13
Supplementary tables1-5,8,10-12
Supplementary mutation lollipop plots

View the discussion thread.

PreviousNext

Posted August 15, 2018.

Download PDF

Supplementary Material

Thank you for your interest in spreading the word about bioRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following The landscape of selection in 551 Esophageal Adenocarcinomas defines genomic biomarkers for the clinic

Message Subject (Your Name) has forwarded a page to you from bioRxiv

Message Body (Your Name) thought you would like to see this page from the bioRxiv website.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

The landscape of selection in 551 Esophageal Adenocarcinomas defines genomic biomarkers for the clinic

AM Frankell, S Jammula, X Li, G Contino, S Killcoyne, S Abbas, J Perner, L Bower, G Devonshire, E Ococks, N Grehan, J Mok, M O’Donovan, S MacRae, M Eldridge, S Tavare, RC Fitzgerald, the Oesophageal Cancer Clinical and Molecular Stratification (OCCAMS) Consortium

bioRxiv 310029; doi: https://doi.org/10.1101/310029

Share This Article: